# Receptor for Advanced Glycation End Products (RAGE) Polymorphisms In Inflammatory Bowel Disease

> **NCT04286659** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 180 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04286659
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2023-03
- **Final completion:** 2023-12
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2020-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04286659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04286659, "Receptor for Advanced Glycation End Products (RAGE) Polymorphisms In Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04286659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*